<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Studies from a single laboratory have shown that in <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent models</z:e> of permanent <z:hpo ids='HP_0001297'>stroke</z:hpo>, administration of the <z:chebi fb="0" ids="26831">sulfonylurea</z:chebi> <z:chebi fb="0" ids="5441">glibenclamide</z:chebi> (Glib) is highly effective in reducing <z:hpo ids='HP_0000969'>edema</z:hpo>, mortality, and lesion volume </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:hpo ids='HP_0001297'>Stroke</z:hpo> Therapy Academic Industry Roundtable (STAIR) recommends that new <z:hpo ids='HP_0011009'>acute</z:hpo> treatments for <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> to be replicated across different laboratories </plain></SENT>
<SENT sid="2" pm="."><plain>Accordingly, we examined the effect of low-dose Glib in a permanent suture occlusion model of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Male Sprague-Dawley rats underwent permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (pMCAO) followed by an initial intraperitoneal injection of Glib (10 μg/kg) and the start of a constant infusion (200 ng/h) via miniosmotic pump at the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Functional deficits were assessed by Neurological Severity Score (NSS) and grip-strength meter at 24 and 48 h after pMCAO </plain></SENT>
<SENT sid="5" pm="."><plain>Glib-treated rats showed a significant reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, lower NSS, and less hemispheric swelling compared to vehicle </plain></SENT>
<SENT sid="6" pm="."><plain>Grip strength was decreased significantly in pMCAO rats compared to shams and significantly improved by treatment with Glib </plain></SENT>
<SENT sid="7" pm="."><plain>Taken together, these data indicate that Glib has strong neuroprotective effects following <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and may warrant further testing in future clinical trials for human <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>